
C.diff Vaccine in Adults 65 Years of Age and Older
Short Title: A Study to Learn About a Clostridioides difficile Vaccine in People 65 Years of Age and Older
Enrollment Status: Recruiting
NCT #: NCT07282665
Specialty Area: Infectious Disease
Condition Studied: C.difficile Infection
Age Group: Older Adult
Phase: III
Study Information
Summary / Purpose
To evaluate the efficacy, safety, and tolerability of Clostridioides (formerly Clostridium) difficile (C. difficile) adjuvanted vaccine in reducing the incidence of primary C. difficile infection (pCDI) in adults ≥65 years of age
Who Can Participate
- Adults 65+ years of age
- Increased risk of future development of Clostridoides difficile infection
- No prior episode of C. difficile infection, small- or large bowel resection, metastatic malignancy, or end-state renal disease
What's Involved
- Random assignment to receive the study medication or placebo given as 2 injections
- Blood and stool samples
- A study electronic diary
- Questionnaires
Principal Investigator

Additional Information
Address: 1500 E 2nd St. Reno, NV 89502
General Research: 775-982-3646
Oncology Research: 775-982-5050
Email: Renown-CRD@renown.org
Complete Study Details: https://clinicaltrials.gov/study/NCT07282665
Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.